Clinical Trial Update: Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia [Phase 4]

View source ↗

Summary

A Phase 4 trial in Korean patients with combined hyperlipidemia assessed the tolerability and lipid-lowering efficacy of a rosuvastatin‑fenofibrate combination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Yonsei University | Conditions: Hyperlipidemia | Phase 4 | Status: COMPLETED